Fourteen insulinopenic diabetics were treated with a closedloop Biostator Glucose Controller for 24-48 hours followed by 7-10 days of continuous subcutaneous insulin infusion (CSII) in 12 patients. Percent distribution of pre-meal insulin during optimal control with CSII was predicted by the Biostator (r=0.66, slope = 0.89 x intercept=0.24, P<.001). control during closed-loop feadback, expressed as mean of pre-meal, peak and two hour post meal blood glucose was correlated with HbAlC prior to control (r=0.67, P<.Ol).
Fourteen insulinopenic diabetics were treated with a closedloop Biostator Glucose Controller for 24-48 hours followed by 7-10 days of continuous subcutaneous insulin infusion (CSII) in 12 patients. Percent distribution of pre-meal insulin during optimal control with CSII was predicted by the Biostator (r=0.66, slope = 0.89 x intercept=0.24, P<.001). control during closed-loop feadback, expressed as mean of pre-meal, peak and two hour post meal blood glucose was correlated with HbAlC prior to control (r=0.67, P<.Ol).
During CSII insulin requirements decreased significantly 19f 4.4% MfSE, (Pc.025). The decrease in insulin was accompanied by good glucose control: lllf6.9 vs 100f4.3 mgldl. In the 3 patients displaying the largest decrease in insulin requirements (25-44%) during CSII, initial HbAIC (13.5f1.3%) was greater than in patients whose requirement decreased less (HbAIC 10f.86%, P<.05).
Conclusions 1) Distribution of insulin for-programming of CSII can be established with a closed-loop insulin delivery system and may shorten the time required to achieve optimal metabolic control. 2) Metabolic control during closed-loop insulin delivery is influenced by the previous state of control as assessed by HbAlC levels. 3) Over 7-10 days of tight metabolic control with CSII, insulin requirements decreased, with the greatest decrease occurring in patients who have been in poor control. 7.6'6.0 In all three groups BOHB levels correlated inversely with aae and with glucose concentrations. On fasting, FFA (pC0.025) and BOHB (~40.025) were lower in GH-deficient than in normal children. Although hGH treatment caused only a small increase in FFA (pL0.25). BOHB increased significantly (pC0.05).
EFFECT OF HUMAN GROWTH HORMONE (hGH) TREATMENT
Although lipolysis and ketogenesis increase in fasting GHdeficient children, growth hormone is required for these processes to occur optimally.
FAT-DERIVED FUELS DURING 24-HOUR STARVATION IN
CHILDREN. Joseph I. Wolfsdorf, &do1 lah Sade_g-hk ' l 9 l -, and Gris Senior. Tufts University School of Medicine, New Enqland Medical Center, Boston.
~uring prolonged fasting, adults show a gradual rise in the blood levels of free fatty acids (FFA) and betahydroxybutyrate (BOHB) . In children, by contrast, ketonuria is frequently present after a relatively short fast and is often viewed as an indication of a pathological process. Despite the importance of fat-derived fuels, there is a surprising scarcity of information concerning blood levels of FFA and ketones in fasting children of various ages. We studied the metabolic response to a 24-hour fast in 23 normal children (mean age=8.3, range 1.9-16.7 years). TIME FFA* BOHR* GLUCOSE* hrs mM mM --mM mean'!'^.^. .27'0.70 There was a rapid and progressive rise in FFA and BOHB concomitant with a fall in glucose. The concentrations achieved at 24 hours were comparable to those seen in fasting adults after about one week. There was an inverse correlation (r=0.701; p<0.001) between fasting BOHB levels and age.
We conclude that moderate ketonemia and ketonuria in children after a relatively brief period of food deprivation is a normal physiologic response. The assessment of ketonuria should depend on quantitative blood assays interpreted according to age. A 25y.o. G4P3Ab. woman who had previously delivered at least one and possibly two infants affected with a holocarboxylase synthetase deficiency was given biotin, lOmg p.0. daily over the last 4 wks. of pregnancy. No attempt at amniocentesis was made because of the late gestational stage of presentation. Twin male infants were delivered by elective C-section at 40 wks. gestation. Fibroblast cultures were begun immediately after birth, assay of which subsequently showed one infant to be normal and the other affected. However, daily monitoring of organic acids in urine and plasma over the first week of life showed no abnormality in either infant, both of whom appeared phenotypically normal. The subsequent clinical course of the affected baby has been reported elsewhere and documented clear biotin-responsiveness of the defect in vivo. Biotin measurements provided evidence that biotin administration during late pregnancy was effective in raising cord blood biotin to 4-7 fold control levels (30-48ng/ ml vs. 7.34?0.55ng/ml).
We conclude that it is possible to safely and effectively raise fetal blood biotin to therapeutic levels by oral administration of lOmg daily to the mother, in this case obviating the need for prenatal diagnosis and its attendant risks. Ellefson, Kanta Kuba, William Krivit, and Bruce A. Kottke.
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University of Minnesota, Minneapolis, Minnesota.
Normal (N) and familial hypercholesterolemic (FHC) siblings' excretion of fecal neutral sterols (FNS) and fecal bile acids (FBA) were compared as a possible mechanism to explain the hypercholesterolemia of FHC.
Fifteen children, 5 N and 10 FHC, age 7-16, were studied on two diets. Diet A contained 188 mg cholesterol per day and Diet B contained 30 mg cholesterol per day. Children were admitted for 14 days. Three pooled stool samples, three days each, were collected with two markers and analyzed for FNS and FBA by TLC and GLC techniques. Fructose-1.6-D'Pase 1 3.6 6.0 5.0 Elevation of Hb Axc, which was lowered by dialysis, was only found in the diabetics (p <.001). In contrast, subjects with Type I GSD and Fructose-1,6-D'Pase deficiency had elevated ~b Ara+b (p <0.001), which was not altered by dialysis. Since these latter disorders are often associated with lactic acidosis and hypoglycemia, glycolytic intermediates in the red bloodcells are likely adducts. Analysis of the individualminorhemoglobins may serve in the screening and management of these disorders.
